Blood group antigens SLeX, SLeA, and LeY as prognostic markers in endometrial cancer

PURPOSE: Endometrial cancer (EC) is the most common gynecological cancer worldwide. Treatment has been improved in recent years, but, in advanced stages, therapeutical options are still limited. It has been reported that the expression of the blood group antigens Sialyl Lewis X (SLeX), Sialyl Lewis...

Descripción completa

Detalles Bibliográficos
Autores principales: Kolben, Thomas, Müller, Lena, Meister, Sarah, Keilmann, Lucia, Buschmann, Christina, Trillsch, Fabian, Burges, Alexander, Czogalla, Bastian, Mitter, Sophie, Schmoeckel, Elisa, Corradini, Stefanie, Mahner, Sven, Jeschke, Udo, Kessler, Mirjana, Beyer, Susanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article – Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587092/
https://www.ncbi.nlm.nih.gov/pubmed/35729354
http://dx.doi.org/10.1007/s00432-022-04098-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587092/
https://www.ncbi.nlm.nih.gov/pubmed/35729354
http://dx.doi.org/10.1007/s00432-022-04098-8

Ejemplares similares